Skip to content

Stress and Sugar Synergy

Synergistic Effects of Stress and Sugar Feeding on Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02143011
Acronym
SSS
Enrollment
23
Registered
2014-05-20
Start date
2014-04-30
Completion date
2016-12-31
Last updated
2019-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia, Insulin Resistance, Metabolic Syndrome

Keywords

sugar, sucrose, fruit juice, orange juice, metabolism, immune cell aging, lipids

Brief summary

The main objectives of this study are to test the hypotheses that: 1) consumption of beverages sweetened with sucrose will increase risk factors for cardiovascular disease to a greater extent than a naturally-sweetened fruit juice such as orange juice, and 2) chronic psychological stress may augment the adverse metabolic effects of sugar intake. The study intervention consists of 2-week's consumption of 25% of energy as sugar provided either as a sucrose-sweetened beverage or naturally-sweetened orange juice.

Interventions

OTHERorange juice

intervention assigned: 2-week consumption of naturally-sweetened orange juice providing 25% of energy requirement

OTHERsucrose

intervention assigned: 2-week consumption of sucrose-sweetened beverage providing 25% of energy requirement

Sponsors

University of California, San Francisco
CollaboratorOTHER
USDA, Western Human Nutrition Research Center
CollaboratorFED
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Body mass index between 28-35 * Self report of stable body weight during the past six months * High stress participants: Perceived Stress Scores (PSS) ≥ 24, and the presence of a predefined chronically stressful event as assessed by the Telephone screening questions. (IDS scores are not an inclusion criteria in this group, merely a rule-out for the low stress participants). * Low stress participants: PSS scores ≤ 8, Inventory for Depressive Symptom (IDS) scores ≤ 14, and the absence of any predefined chronically stressful events as assessed by the telephone screening questions.

Exclusion criteria

* glucose intolerance * Evidence of liver disorder * Evidence of kidney disorder * Evidence of thyroid disorder * Systolic blood pressure consistently over 140mmHg or diastolic blood pressure over 90mmHg * Triglycerides \> 200mg/dl * LDL-C \> 130mg/dl * Hemoglobin \< 8.5 g/dl * pregnant or lactating women * Current, prior (within 12 months), or anticipated use of any hypolipidemic or anti-diabetic agents * Use of Selective Serotonin Reuptake Inhibitors and anti-hypertensive medications * Any other condition that, in the opinion of the investigators, would put subject at risk * Strenuous exerciser * surgery for weight loss * Diet exclusions: food allergies, special dietary restrictions, habitual ingest of \>2 alcoholic beverages/day

Design outcomes

Primary

MeasureTime frameDescription
24-hour triglyceride area under the curveBaseline and 2-week intervention28 serial blood samples are collected over a 24 hour period.

Secondary

MeasureTime frame
Markers of immune cell agingBaseline and 2-week intervention

Other

MeasureTime frame
3 hour oral glucose tolerance testBaseline and 2-week intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026